Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples

被引:24
作者
Speights, VO
Cohen, MK
Riggs, MW
Coffield, KS
Keegan, G
Arber, DA
机构
[1] TEXAS A&M UNIV,COLL MED,HLTH SCI CTR,DEPT PATHOL,SCOTT & WHITE CLIN & MEM HOSP,TEMPLE,TX 76508
[2] TEXAS A&M UNIV,COLL MED,HLTH SCI CTR,DEPT BIOSTAT,SCOTT & WHITE CLIN & MEM HOSP,TEMPLE,TX 76508
[3] TEXAS A&M UNIV,COLL MED,HLTH SCI CTR,DEPT UROL,SCOTT & WHITE CLIN & MEM HOSP,TEMPLE,TX 76508
来源
BRITISH JOURNAL OF UROLOGY | 1997年 / 80卷 / 02期
关键词
prostate cancer; transurethral resection; neuroendocrine markers; proliferative index;
D O I
10.1046/j.1464-410X.1997.00359.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine whether the quantification of certain neuroendocrine and proliferative markers would help in the prognostic evaluation of prostatic adenocarcinomas obtained during transurethral resection of the prostate (TURF). Materials and methods Samples from two groups of patients with prostate cancer were examined. One group comprised 23 patients, of whom 12 were stage TV and 11 stage III, all with Gleason scores of greater than or equal to 7; this group was designated as high-grade, high-stage (HGHS). The second group comprised 10 consecutive patients with stage Tla adenocarcinoma of the prostate with Gleason scores of less than or equal to 6, designated as low-grade, low-stage (LGLS) tumours. Tumour tissue from each TURF was stained with MIB-1 (an indicator of cell proliferation), neuron-specific enolase (NSE), chromogranin A (ChA) and synaptophysin (Syn), and 1000 cells counted to determine the percentages of positive cells in both benign and malignant tissue. The percentage of MIB-1-positive cells was designated as the proliferative index (PI). Patients were clinically followed to evaluate tumour progression, documented by rising prostate-specific antigen (PSA) levels, X-ray evidence of recurrent or metastatic carcinoma, or tissue biopsy showing malignancy. Results The mean number of neuroendocrine cells (NEC) for each marker and the mean PI were greater in the HGHS tumours than in the LGLS tumours or surrounding benign tissue of either group (P < 0.01). The LGLS tumours were remarkable for a having mean PI of about twice that of the benign tissue (2.9 and 1.3, respectively, P < 0.01); the NEC in these cases were more frequent in the benign than in the malignant tissue, There was no significant difference between the mean PIs and the mean percentages of NEC in the 14 HGHS tumours that progressed and the nine HGHS tumours that did not (P values 0.37-0.96). Conclusions Although the PI assessed by MIB-1 and the number of NEC-positive cells were much higher in HGHS than LGLS tumours, this finding did not appear to have independent prognostic significance, The significance of the higher PI in LGLS tumours than in corresponding benign tissue is uncertain; LGLS tumours bad fewer NEC than the surrounding benign tissue. The quantification of any of these four markers (MIB-1, NSE, ChA, Syn) was not prognostically helpful in these groups of cancers present in TURF specimens.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 34 条
[1]   THE COURSE OF NEURO-ENDOCRINE DIFFERENTIATION IN PROSTATIC CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY TESTING CHROMOGRANIN-A AS AN ENDOCRINE MARKER [J].
ABRAHAMSSON, PA ;
FALKMER, S ;
FALT, K ;
GRIMELIUS, L .
PATHOLOGY RESEARCH AND PRACTICE, 1989, 185 (03) :373-380
[2]  
*AM JOINT COMM CAN, 1992, MAN STAG CANC, P181
[3]   NEUROENDOCRINE DIFFERENTIATION IN METASTATIC PROSTATIC ADENOCARCINOMA [J].
APRIKIAN, AG ;
CORDONCARDO, C ;
FAIR, WR ;
ZHANG, ZF ;
BAZINET, M ;
HAMDY, SM ;
REUTER, VE .
JOURNAL OF UROLOGY, 1994, 151 (04) :914-919
[4]  
APRIKIAN AG, 1993, CANCER, V71, P3952, DOI 10.1002/1097-0142(19930615)71:12<3952::AID-CNCR2820711226>3.0.CO
[5]  
2-X
[6]   HORMONE-RESISTANT PROSTATIC ADENOCARCINOMA - AN EVALUATION OF PROGNOSTIC FACTORS IN PRETREATMENT AND POSTTREATMENT SPECIMENS [J].
BERNER, A ;
NESLAND, JM ;
WAEHRE, H ;
SILDE, J ;
FOSSA, SD .
BRITISH JOURNAL OF CANCER, 1993, 68 (02) :380-384
[7]   DNA-PLOIDY, SERUM PROSTATE-SPECIFIC ANTIGEN, HISTOLOGICAL GRADE AND IMMUNOHISTOCHEMISTRY AS PREDICTIVE PARAMETERS OF LYMPH-NODE METASTASES IN T1-T3/MO PROSTATIC ADENOCARCINOMA [J].
BERNER, A ;
WAERE, H ;
NESLAND, JM ;
PAUS, E ;
DANIELSEN, HE ;
FOSSA, SD .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (01) :26-32
[8]   NEUROENDOCRINE DIFFERENTIATION IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND ADENOCARCINOMA [J].
BOSTWICK, DG ;
DOUSA, MK ;
CRAWFORD, BG ;
WOLLAN, PC .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (12) :1240-1246
[9]   PROLIFERATING CELL NUCLEAR ANTIGEN CYCLIN IN INCIDENTAL CARCINOMA OF THE PROSTATE [J].
BOTTICELLI, AR ;
CRISCUOLO, M ;
MARTINELLI, AM ;
BOTTICELLI, L ;
FILONI, A ;
MIGALDI, M .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1993, 423 (05) :365-368
[10]   CELL-PROLIFERATION IN PROSTATIC ADENOCARCINOMA - INVITRO MEASUREMENT BY 5-BROMODEOXYURIDINE INCORPORATION AND PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION [J].
CARROLL, PR ;
WALDMAN, FM ;
ROSENAU, W ;
COHEN, MB ;
VAPNEK, JM ;
FONG, P ;
NARAYAN, P ;
MAYALL, BH .
JOURNAL OF UROLOGY, 1993, 149 (02) :403-407